SkinBioTherapeutics's total assets for Q2 2024 were £7.30M, an increase of 39.91% from the previous quarter. GB:SBTX total liabilities were £2.81M for the fiscal quarter, a 25.10% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.